JPS645878B2 - - Google Patents

Info

Publication number
JPS645878B2
JPS645878B2 JP57092583A JP9258382A JPS645878B2 JP S645878 B2 JPS645878 B2 JP S645878B2 JP 57092583 A JP57092583 A JP 57092583A JP 9258382 A JP9258382 A JP 9258382A JP S645878 B2 JPS645878 B2 JP S645878B2
Authority
JP
Japan
Prior art keywords
medium
polyhydric alcohol
cells
interferon
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57092583A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58209993A (ja
Inventor
Masahiro Nobuhara
Kyoshi Yamaguchi
Suguru Mochida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP57092583A priority Critical patent/JPS58209993A/ja
Priority to US06/496,506 priority patent/US4548900A/en
Priority to GB08314400A priority patent/GB2121806B/en
Priority to CA000429218A priority patent/CA1195274A/en
Priority to FR8309002A priority patent/FR2527448B1/fr
Priority to DE19833319714 priority patent/DE3319714A1/de
Publication of JPS58209993A publication Critical patent/JPS58209993A/ja
Publication of JPS645878B2 publication Critical patent/JPS645878B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP57092583A 1982-05-31 1982-05-31 インタ−フエロンの産生方法 Granted JPS58209993A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP57092583A JPS58209993A (ja) 1982-05-31 1982-05-31 インタ−フエロンの産生方法
US06/496,506 US4548900A (en) 1982-05-31 1983-05-20 Method of interferon production
GB08314400A GB2121806B (en) 1982-05-31 1983-05-25 Method of interferon production
CA000429218A CA1195274A (en) 1982-05-31 1983-05-30 Method of interferon production
FR8309002A FR2527448B1 (fr) 1982-05-31 1983-05-31 Procede de production d'interferon
DE19833319714 DE3319714A1 (de) 1982-05-31 1983-05-31 Verfahren zur interferonherstellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57092583A JPS58209993A (ja) 1982-05-31 1982-05-31 インタ−フエロンの産生方法

Publications (2)

Publication Number Publication Date
JPS58209993A JPS58209993A (ja) 1983-12-07
JPS645878B2 true JPS645878B2 (enExample) 1989-02-01

Family

ID=14058451

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57092583A Granted JPS58209993A (ja) 1982-05-31 1982-05-31 インタ−フエロンの産生方法

Country Status (6)

Country Link
US (1) US4548900A (enExample)
JP (1) JPS58209993A (enExample)
CA (1) CA1195274A (enExample)
DE (1) DE3319714A1 (enExample)
FR (1) FR2527448B1 (enExample)
GB (1) GB2121806B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58209993A (ja) * 1982-05-31 1983-12-07 Mochida Pharmaceut Co Ltd インタ−フエロンの産生方法
US4551429A (en) * 1983-09-15 1985-11-05 American Home Products Corporation Stimulation of antigen production by Bordetella pertussis
JPS6274284A (ja) * 1985-09-27 1987-04-06 Teijin Ltd 動物細胞の培養方法
DE3785086T2 (de) * 1986-06-04 1993-07-08 Agency Ind Science Techn Zubereitung fuer zellkultur und ihre verwendung.
JPS62285780A (ja) * 1986-06-04 1987-12-11 Agency Of Ind Science & Technol 動物細胞増殖用組成物および増殖方法
JP2520681B2 (ja) * 1986-08-04 1996-07-31 ザ ユニバーシティ オブ ニュー サウス ウェールズ 生合成のヒトの成長ホルモン製品
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
EP0761229B1 (en) * 1995-03-17 2004-08-04 Toray Industries, Inc. Corneal vascularization inhibitor
US6855519B2 (en) * 1995-08-22 2005-02-15 The Regents Of The University Of California Methods for enhancing the production of interferon in cell culture
US5840565A (en) 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US7367961B2 (en) * 2004-09-10 2008-05-06 Depuy Spine, Inc. Intradiscal injection of autologous interferon

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413198A (en) * 1966-06-30 1968-11-26 Calbiochem Reagents and method for assaying biological samples
US3876375A (en) * 1971-11-22 1975-04-08 Jonas Maurukas Biological composition for use as a reference control in diagnostic analysis
EP0005476B1 (de) * 1978-05-17 1981-12-30 Dr. Karl Thomae GmbH Verfahren zur Herstellung von Humaninterferon
EP0014050A3 (en) * 1979-01-16 1980-10-01 Beecham Group Plc Interferon production
US4198479A (en) * 1979-03-30 1980-04-15 Merck & Co., Inc. Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
JPS58209993A (ja) * 1982-05-31 1983-12-07 Mochida Pharmaceut Co Ltd インタ−フエロンの産生方法
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides

Also Published As

Publication number Publication date
GB2121806B (en) 1985-06-26
CA1195274A (en) 1985-10-15
FR2527448B1 (fr) 1986-12-12
FR2527448A1 (fr) 1983-12-02
GB2121806A (en) 1984-01-04
GB8314400D0 (en) 1983-06-29
DE3319714A1 (de) 1983-12-01
JPS58209993A (ja) 1983-12-07
DE3319714C2 (enExample) 1988-05-11
US4548900A (en) 1985-10-22

Similar Documents

Publication Publication Date Title
De Maeyer et al. Interferons
Duc-Goiran et al. Unusual apparently constitutive interferons and antagonists in human placental blood.
KR940008978B1 (ko) 안정성이 증대된 재조합 감마 인터페론 및 그의 제조 방법
JPS645878B2 (enExample)
EP0053135B1 (en) Production of ifn-gamma
EP0611305A1 (en) Stabilization of human interferon
Kelley et al. Characterization of a mouse interferon gene locus II. Differential expression of α-interferon genes
EP0172007B1 (en) Stable liposomes with aqueous-soluble medicaments and methods for their preparation
Jameson et al. Bluetongue virus, an exceptionally potent interferon inducer in mice
Fish et al. Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters
JPH0112760B2 (enExample)
Armstrong Interferons and their applications
US4614651A (en) Interferon epsilon
JPS6219406B2 (enExample)
JPH0428279B2 (enExample)
Trapman A systematic study of interferon production by mouse L-929 cells induced with poly (I)-poly (C) and DEAE-dextran
Diamantstein Stimulation of humoral immune response by tilorone hydrochloride
EP0301314B1 (en) A method for the purification of interferon
Krempien et al. Purification of chick interferon by zinc chelate affinity chromatography and sodium dodecylsulfate-polyacrylamide gel electrophoresis
Werenne et al. Antiviral effect of bacterially produced human interferon (Hu-IFNα2) against experimental vaccinia infection in calves
Hughes et al. Do the interferons act singly or in combination?
EP0048283A1 (en) Virus-inhibiting substance and process for preparing the same
Cesario et al. Relationship between the physicochemical nature of human interferon, the cell induced, and the inducing agent
Schellekens et al. The chimpanzee as a model to test the side effects of human interferons
Hilleman et al. Double-stranded RNA’s in relation to interferon induction and adjuvant activity